Acute Maternal and Fetal Effects of Exercise in Pregnancy (EXPREG)

March 4, 2013 updated by: Isabela Coutinho, Instituto Materno Infantil Prof. Fernando Figueira

Acute Effects on the Mother and Fetus in Two Modalities of Exercise in Pregnancy: a Randomized Controlled Trial.

This will be an open randomized clinical trial involving pregnant women between 35 and 37 weeks randomized to two modalities of exercise: treadmill or stationary bike. The study hypothesis is that exercise on a stationary cycle causes less maternal and fetal effects in relation to treadmill exercise.We will study the acute effects of exercise for both the mother and the fetus, monitoring the parameters before, during and after exercise for 20 minutes. The exercise intensity will be moderate, remaining between 60% and 80% of maximum heart rate. Women will be monitored with a recording equipment of ABPM (ambulatory blood pressure monitorization) and continuous cardiotocography and blood will be collected to measure blood glucose, total cholesterol and HDL, nitrate and lactate before, during and after exercise. The analysis variables are: maternal heart rate and blood pressure, fetal heart rate, number of fetal movements, transient accelerations, decelerations, short-term variability, episodes of high variability, uterine tone, glucose, lactate, nitrate, total cholesterol and HDL.The analysis will be based on intention to treat, according to the recommendations of the CONSORT (2010).

Study Overview

Detailed Description

Background: Exercise has been encouraged during pregnancy in order to reduce undesirable outcomes such as pre-eclampsia, excessive weight gain and diabetes. Despite widespread among pregnant women and obstetricians, little is known about the acute effects for both mother and fetus at the time of exercise, with most existing research controlling only the pre-and post-exercise.

Objective: To study the acute effects of two moderate modalities of exercise on the pregnant woman and fetus.

Methods: This will be an open randomized controlled trial to be conducted in Campina Grande, Brazil, from December 2011 to December 2012. The pregnant women with gestational age between 35 and 37 weeks will be randomized into two groups of moderate-intensity exercise: treadmill and stationary bicycle. Pregnant women and fetuses will be monitored for 60 minutes divided in three steps of 20 minutes each: baseline assessment, monitoring during exercise and recovery period. Women will be monitored using a recording equipment of ABPM (ambulatory blood pressure monitorization) and fetal heart rate will be monitored through computerized cardiotocography. Blood will be collected to measure blood glucose, total cholesterol and HDL, nitrate and lactate before, during and after exercise. The intensity of exercise will be maintained between 60% and 80% of maximum heart rate by Karvonen formula, in addition to the subjective perception of exertion on the modified Borg scale (moderate intensity). During the monitoring period (in the three moments mentioned above) blood will be collected for the measurement of glucose, total cholesterol and HDL, nitrate and lactate. The analysis variables are: maternal heart rate and blood pressure, fetal heart rate, number of fetal movements, transient accelerations, decelerations, short-term variability, episodes of high variability, uterine tone, glucose, lactate, nitrate, total cholesterol and HDL

Statistical Analysis: Statistical analysis will be performed using Epi Info 3.5.3 and Medcalc 11.6.6.0 or higher versions available at the time. The analysis will be based on intention to treat, according to the recommendations of the CONSORT (2010). For comparison of levels of glucose, lactate, cholesterol, nitrate, maternal blood pressure, maternal and fetal heart rate, fetal movements, transient accelerations, decelerations, changes in short-term episodes of high variation, and uterine tone in the two groups a parametric test will be used (Student's t) if these variables have normal distribution, otherwise they will be evaluated using the nonparametric test of Mann-Whitney. To determine the association between mode of exercise and frequency of fetal bradycardia the chi-square test of association (Pearson) will be used at a 5% significance level. The risk ratio (RR) will be calculated as a measure of relative risk, as well as its 95% confidence interval. If a significant difference in the rate of bradycardia will be demonstrated between the groups, the NNH (Number Need Harm) will be calculated.

Ethical issues: The research project was approved by Institutional Review Board under the number CAAE 0195.0.133.000-11 All the participants will be informed about the objectives of the research and only will be included if they agree voluntarily to participate and sign an informed consent term. There are no conflicts of interest.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Paraíba
      • Campina Grande, Paraíba, Brazil, 58406120
        • Instituto Paraibano de Pesquisa Prof. Joaquim Amorim Neto

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 49 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Single pregnancy
  • Alive fetus
  • Gestational age between 35 and 37 weeks
  • Previous sedentarity

Exclusion Criteria:

  • Smoking
  • Chronic maternal illness
  • Diseases that affect respiratory capacity
  • Physical handicap precluding performing exercise
  • Arterial Hypertension
  • Diabetes in Pregnancy
  • Placenta praevia
  • Preterm labor
  • Bleeding in the third trimester
  • Fetal Growth Restriction
  • Oligo-hydramnios
  • Brain-sparing effect
  • Fetal malformations
  • Medical contraindications for performing exercise

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Treading mill exercise
Pregnant women in this group will perform treadmill exercise during 20 minutes. The intensity of exercise will be maintained between 60% and 80% of maximum heart rate by Karvonen formula, in addition to the subjective perception of exertion on the modified Borg scale (moderate intensity).
Two modalities of exercise will be compared: treading mill and stationary bicycle. Pregnant women enrolled in the study will perform exercise during 20 minutes and will be monitored 20 minutes before, during and 20 minutes after exercise.
Other: Stationary bicycle exercise
Pregnant women in this group will perform exercise using a stationary bicycle. The intensity of exercise will be maintained between 60% and 80% of maximum heart rate by Karvonen formula, in addition to the subjective perception of exertion on the modified Borg scale (moderate intensity).
Two modalities of exercise will be compared: treading mill and stationary bicycle. Pregnant women enrolled in the study will perform exercise during 20 minutes and will be monitored 20 minutes before, during and 20 minutes after exercise.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fetal bradycardia
Time Frame: 60 minutes
Fetal heart rate will be monitored durante 60 minutes, 20 minutes before, 20 minutes during and 20 minutes after two modalities of exercise: treading mill and stationary bicycle. The frequency of fetal bradycardia will be assessed.
60 minutes

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maternal blood pressure
Time Frame: 60 minutes
Maternal blood pressure will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Maternal heart rate
Time Frame: 60 minutes
Maternal heart rate will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Glycemia
Time Frame: 60 minutes
Maternal glycemia will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Maternal lactate
Time Frame: 60 minutes
Maternal heart rate will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Maternal nitrate
Time Frame: 60 minutes
Maternal nitrate will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Total Cholesterol and HDL
Time Frame: 60 minutes
Total Cholesterol and HDL will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise)
60 minutes
Fetal heart rate
Time Frame: 60 minutes
Fetal heart rate will be monitored during 60 minutes (20 minutes before, 20 minutes during and 20 minutes after the exercise). The following parameters will be assessed: fetal heart rate, bradycardia, fetal movements, transient accelerations, decelerations, changes in short-term episodes of high variation
60 minutes
Uterine tone
Time Frame: 60 minutes
Uterine tone will be assessed 20 minutes before, 20 minutes during and 20 minutes after exercise
60 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Melania MR Amorim, MD, PhD, Instituto Materno Infantil Prof. Fernando Figueira

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

December 1, 2012

Study Completion (Actual)

December 1, 2012

Study Registration Dates

First Submitted

June 27, 2011

First Submitted That Met QC Criteria

June 27, 2011

First Posted (Estimate)

June 28, 2011

Study Record Updates

Last Update Posted (Estimate)

March 5, 2013

Last Update Submitted That Met QC Criteria

March 4, 2013

Last Verified

March 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • EXPREG 2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hypoglycemia

Clinical Trials on Physical exercise

3
Subscribe